Fetal lung maturity testing in diabetic mothers: Utility of TDx-FLM II surfactant-to-albumin assay, disaturated phosphatidylcholine, and logistic regression models

Laboratory Medicine

Volumn 38, Issue 9, 2007, Pages 553-555

  Melanson, Stacy E F ^a   Jarolim, Petr ^a   McElrath, Thomas F ^a   Berg, Anders ^a   Tanasijevic, Milenko J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; LUNG SURFACTANT; PHOSPHATIDYLCHOLINE;

ADULT; ARTICLE; ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DIABETES MELLITUS; FETUS; FETUS LUNG MATURATION; FLUORESCENCE POLARIZATION; GESTATIONAL AGE; HUMAN; LABORATORY TEST; NEONATAL RESPIRATORY DISTRESS SYNDROME; OUTCOME ASSESSMENT; PREDICTION; PREGNANCY; PREGNANCY DIABETES MELLITUS; PROBABILITY; PROGNOSIS; STATISTICAL MODEL;

EID: 36648999182     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/6PBDFW7FADQDB4D2     Document Type: Article

References (18)

1. Piazee JJ, Anceschi MM, Maranghi L, et al. Fetal lung maturity in pregnancies complicated by insulin-dependent and gestational diabetes: A matched cohort study. Eur J Obstet Gynecol. 1999;83:145-150.
2. Moore TR. A comparison of amniotic fluid fetal pulmonary phospholipids in normal and diabetic pregnancy. Am J Obstet Gynecol. 2002;186:641-650.
3. Piper JM. Lung maturation in diabetes in pregnancy: If and when to test. Semin Perinatol. 2002;26:206-209.
4. Piper JM, Xenakis EM, Langer O. Delayed appearance of pulmonary maturation markers is associated with poor glucose control in diabetics. J Matern Fetal Med. 1998;7:148-153.
5. Piper JM, Langer O. Does maternal diabetes delay fetal pulmonary maturity? Am J Obstet Gynecol. 1993;168:783-786.
6. Langer O. The controversy surrounding fetal lung maturity in diabetes in pregnancy: A re-evaluation. J Matern Fetal Neonatal Med. 2002;12:428-432.
7. Tyden O, Eriksson UJ, Berne C. Fetal lung maturation in diabetic pregnancy. Acta Endocrinol Suppl (Copenh). 1986;277:101-106.
8. Robert MF, Neff RK, Hubbel JP, et al. Association between maternal diabetes and the respiratory-distress syndrome in newborns. N Engl J Med. 1976;294:357-360.
9. Gluck L, Kulovich MV. Lecithin/sphingomyelin ratios in amniotic fluid in normal and abnormal pregnancies. Am J Obstet Gynecol. 1973;115:253-267.
10. Delgado JC, Greene MF, Winkelman JW, et al. Comparison of disaturated phosphatidylcholine and fetal lung maturity surfactant/albumin ratio in diabetic and nondiabetic pregnancies. Am J Clin Pathol. 2000;113:233-239.
11. Tanasijevic MJ, Wybenga DR, Richardson D, et al. A predictive model for fetal lung maturity employing gestational age and test results. Am J Clin Pathol. 1994;102:788-793.
12. Kjos SL, Berkowitz KM, Kung B. Prospective delivery of reliably dated term infants of diabetic mothers without determination of fetal lung maturity: Comparison to historical control. J Matern Fetal Neonatal Med. 2002;12:433-437.
13. Ferroni KM, Gross TL, Sokol RJ, et al. What affects fetal pulmonary maturation during diabetic pregnancy? Am J Obstet Gynecol. 1984;150:270-274.
14. Livingston EG, Herbert WNP, Hage ML, et al. Use of the TDx-FLM Assay in evaluating fetal lung maturity in an insulin-dependent diabetic population. Obstet Gynecol. 1995;86:826-829.
15. Tanasijevic MJ, Winkelman JW, Wybenga DR, et al. Prediction of fetal lung maturity in infants of diabetic mothers using the FLM S/A and disaturated phosphatidylcholine tests. Am J Clin Pathol. 1996;105:17-22.
16. Melanson SEF, Berg A, Jarolim P, et al. Validation of a formula that calculates the estimated risk of respiratory distress syndrome. Obstet Gynecol. 2006;108:1471-1476.
17. McElrath TF, Colon I, Hecht J, et al. Neonatal respiratory distress syndrome as a function of gestational age and an assay for surfactant-to-albumin ratio. Obstet Gynecol. 2004;103:463-468.
18. Torday J, Carson L, Lawson EE. Saturated phosphatidylcholine in amniotic fluid and prediction of the respiratoty-distress syndrome. N Engl J Med. 1979;301:1013-1018.